1. Home
  2. INTT vs GNLX Comparison

INTT vs GNLX Comparison

Compare INTT & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTT
  • GNLX
  • Stock Information
  • Founded
  • INTT 1981
  • GNLX 2001
  • Country
  • INTT United States
  • GNLX United States
  • Employees
  • INTT N/A
  • GNLX N/A
  • Industry
  • INTT Semiconductors
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTT Technology
  • GNLX Health Care
  • Exchange
  • INTT Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • INTT 77.3M
  • GNLX 112.5M
  • IPO Year
  • INTT 1997
  • GNLX 2023
  • Fundamental
  • Price
  • INTT $7.53
  • GNLX $3.44
  • Analyst Decision
  • INTT Strong Buy
  • GNLX Strong Buy
  • Analyst Count
  • INTT 2
  • GNLX 4
  • Target Price
  • INTT $12.00
  • GNLX $17.75
  • AVG Volume (30 Days)
  • INTT 29.7K
  • GNLX 152.2K
  • Earning Date
  • INTT 08-01-2025
  • GNLX 08-13-2025
  • Dividend Yield
  • INTT N/A
  • GNLX N/A
  • EPS Growth
  • INTT N/A
  • GNLX N/A
  • EPS
  • INTT N/A
  • GNLX N/A
  • Revenue
  • INTT $127,503,000.00
  • GNLX N/A
  • Revenue This Year
  • INTT N/A
  • GNLX N/A
  • Revenue Next Year
  • INTT $10.07
  • GNLX N/A
  • P/E Ratio
  • INTT N/A
  • GNLX N/A
  • Revenue Growth
  • INTT 5.19
  • GNLX N/A
  • 52 Week Low
  • INTT $5.24
  • GNLX $1.60
  • 52 Week High
  • INTT $11.92
  • GNLX $5.89
  • Technical
  • Relative Strength Index (RSI)
  • INTT 58.40
  • GNLX 65.71
  • Support Level
  • INTT $7.01
  • GNLX $2.80
  • Resistance Level
  • INTT $8.14
  • GNLX $3.61
  • Average True Range (ATR)
  • INTT 0.45
  • GNLX 0.22
  • MACD
  • INTT 0.02
  • GNLX 0.05
  • Stochastic Oscillator
  • INTT 63.38
  • GNLX 80.23

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: